000 | 01270 a2200301 4500 | ||
---|---|---|---|
005 | 20250514023602.0 | ||
264 | 0 | _c20020731 | |
008 | 200207s 0 0 eng d | ||
022 | _a1087-2906 | ||
024 | 7 |
_a10.1089/108729001753411335 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGüimil García, R | |
245 | 0 | 0 |
_aSynthesis of oligonucleotide inhibitors of DNA (Cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites. _h[electronic resource] |
260 |
_bAntisense & nucleic acid drug development _cDec 2001 |
||
300 |
_a369-78 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCytosine _xanalogs & derivatives |
650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferases _xantagonists & inhibitors |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 |
_aOligodeoxyribonucleotides, Antisense _xchemical synthesis |
700 | 1 | _aBrank, A S | |
700 | 1 | _aChristman, J K | |
700 | 1 | _aMarquez, V E | |
700 | 1 | _aEritja, R | |
773 | 0 |
_tAntisense & nucleic acid drug development _gvol. 11 _gno. 6 _gp. 369-78 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/108729001753411335 _zAvailable from publisher's website |
999 |
_c11747615 _d11747615 |